AI-ECG Tracker vs DeepRhythmAI

Direct competitors — feature-level head-to-head below. Comparability 90/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Shenzhen Carewell Electronics Co.
VS
by Medicalgorithmics S.A.

AI Verdict

Both AI-ECG Tracker and DeepRhythmAI are FDA-cleared, AI-powered solutions for cardiac arrhythmia detection and ECG analysis, positioning them as direct competitors. AI-ECG Tracker offers an on-premise workstation with optional cloud services and a broader range of ECG diagnostic classifications, while DeepRhythmAI is a cloud-based, device-agnostic algorithm emphasizing extensive training data and workflow efficiency. The optimal choice would depend on a healthcare provider's preference for deployment model and the specific breadth of ECG analysis required.

Choose AI-ECG Tracker if…

Choose AI-ECG Tracker if your organization requires a comprehensive, high-accuracy ECG auto-diagnosis system with a preference for on-premise deployment and dedicated workstation capabilities. This tool is ideal for facilities needing rapid analysis (approximately 3 seconds) of 12-lead ECGs for a wide range of cardiac abnormalities, including myocardial ischemia and infarction, with robust local review and reporting features. It suits environments where a powerful GPU workstation for fast computing and a Windows-based professional client for detailed annotation are priorities.

View AI-ECG Tracker →

Choose DeepRhythmAI if…

Choose DeepRhythmAI if your primary need is a highly accurate, cloud-based AI algorithm specifically for cardiac arrhythmia detection and classification across a variety of ECG devices. This solution is best for healthcare providers seeking to significantly streamline clinical workflows, reduce missed diagnoses of arrhythmias, and leverage a device-agnostic platform that integrates easily via API. It's well-suited for organizations adopting a cloud-first strategy for diagnostics and prioritizing efficiency and scalability in arrhythmia analysis.

View DeepRhythmAI →

For physicians evaluating AI-powered ECG analysis tools, AI-ECG Tracker and DeepRhythmAI offer distinct approaches. AI-ECG Tracker, from Shenzhen Carewell Electronics Co. (a Lepu Medical subsidiary), excels in comprehensive, rapid auto-diagnosis across 16 cardiac classifications and 104 ECG diagnostic classifications, including arrhythmias, hypertrophy, and ischemia. Its on-premise deployment with an optional cloud service provides a robust workstation for fast computing and a professional diagnostic client for detailed review and report generation. This tool is best suited for practices or institutions seeking an integrated, high-accuracy solution with local control over data processing and a broad spectrum of diagnostic support.

DeepRhythmAI, by Medicalgorithmics S.A., specializes in revolutionizing cardiac arrhythmia detection and classification. As an FDA-cleared, cloud-based algorithm, it leverages advanced CNN and Transformer models trained on an extensive dataset of over 250 billion annotated heartbeats. Its key practical difference lies in its cloud-native, device-agnostic nature, allowing seamless integration with various ECG devices and focusing on superior accuracy and efficiency specifically for arrhythmia diagnostics. Physicians prioritizing a streamlined, cloud-based workflow for highly accurate arrhythmia detection and classification, with the flexibility of device integration and potential for significant workflow efficiency gains, would find DeepRhythmAI to be the more appropriate choice.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature AI-ECG Tracker DeepRhythmAI
Pricing Not publicly available Enterprise
Deployment On-premise (AI-ECG Workstation, Diagnostic Client) with optional cloud service (Lepu Nebula Cloud) for remote diagnostic services. Cloud
FDA Status 1 AI-estimated Cleared AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

DeepRhythmAI

Tool B's purely cloud-based deployment generally offers easier access and less IT overhead for users compared to Tool A's on-premise workstation and Windows client. Its explicit claim of streamlining clinical workflows by up to 65% directly indicates a strong focus on user efficiency and a potentially superior user experience.

Clinical Value

DeepRhythmAI

Both tools are FDA-cleared and offer high accuracy, but Tool B stands out with its claim of reducing missed diagnoses by 14x to 114x. This significant, quantifiable impact on diagnostic accuracy, coupled with its training on over 250 billion annotated heartbeats, suggests a higher clinical value.

Pricing & Value

Tie

Neither tool provides publicly available pricing information, making a direct comparison of their cost-effectiveness impossible. Without transparent pricing details, it is not feasible to determine which offers better value.

Enterprise Readiness

DeepRhythmAI

Tool B explicitly offers API availability and data export capabilities, which are crucial for seamless integration into existing enterprise healthcare systems. Its stated target market from solo practices to large health systems, along with a global customer base, further demonstrates its readiness for diverse enterprise environments.

Innovation

DeepRhythmAI

Tool B showcases a higher degree of innovation by explicitly utilizing advanced CNN and Transformer AI models, which represent cutting-edge deep learning architectures. Its training on an exceptionally vast dataset of over 250 billion annotated heartbeats also highlights a significant technological advancement in the field.

Support & Docs

Tie

The provided structured facts and available public information do not offer specific details regarding the support channels, service level agreements, or documentation quality for either tool. Without this crucial information, it is impossible to distinguish between them in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature AI-ECG Tracker DeepRhythmAI
Name AI-ECG Tracker DeepRhythmAI
Company Shenzhen Carewell Electronics Co. Medicalgorithmics S.A.
Categories Cardiology AI Cardiology AI, Clinical Decision Support & Reference
Specialties Cardiology, Emergency Medicine Cardiology
Key Features (Summary) AI-powered ECG auto-analysis and diagnosis; high accuracy (over 95%) for common cardiac abnormalities; supports 12-lead ECG data collection; rapid diagnosis in approximately 3 seconds; comprehensive diagnosis support for 16 cardiac classifications and 104 ECG diagnostic classifications. AI-powered arrhythmia detection and classification; utilizes CNN and Transformer models; trained on 250 billion+ annotated heartbeats; device-agnostic and integrates with various ECG devices; faster ECG reporting and analysis; reduces missed diagnoses; streamlines clinical workflows.

Videos

Demos, reviews, and walkthroughs featuring AI-ECG Tracker and DeepRhythmAI.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

AI-ECG Tracker provides comprehensive diagnosis support for 16 cardiac classifications and 104 ECG diagnostic classifications, including arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction. DeepRhythmAI focuses on AI-powered arrhythmia detection and classification.
AI-ECG Tracker boasts high accuracy (over 95%) for common cardiac abnormalities and rapid diagnosis in approximately 3 seconds. DeepRhythmAI claims to reduce missed diagnoses by 14x to 114x and streamline clinical workflows with up to a 65% efficiency increase.
DeepRhythmAI is device-agnostic and integrates with various ECG devices, utilizing an API for easy integration with other medical products. AI-ECG Tracker supports 12-lead ECG data collection, but specific details on its integration capabilities with third-party devices are not explicitly provided.
Both tools are designed to support Cardiology. Additionally, AI-ECG Tracker also lists Emergency Medicine as a supported specialty.
AI Tool Finder
AI-powered search. Results may not be comprehensive.